Enovix Co. (NASDAQ:ENVX - Free Report) - Research analysts at Northland Capmk issued their Q1 2026 earnings estimates for shares of Enovix in a research note issued to investors on Thursday, February 20th. Northland Capmk analyst G. Richard expects that the company will earn ($0.27) per share for the quarter. The consensus estimate for Enovix's current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix's Q2 2026 earnings at ($0.27) EPS, Q3 2026 earnings at ($0.27) EPS and Q4 2026 earnings at ($0.27) EPS.
Enovix (NASDAQ:ENVX - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) earnings per share for the quarter, beating analysts' consensus estimates of ($0.18) by $0.01. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. The company had revenue of $9.72 million during the quarter, compared to analysts' expectations of $8.77 million.
Other research analysts have also recently issued reports about the company. Janney Montgomery Scott cut Enovix from a "buy" rating to a "neutral" rating and set a $10.00 price target for the company. in a report on Thursday, October 31st. Craig Hallum lowered their price objective on shares of Enovix from $20.00 to $18.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Cantor Fitzgerald restated an "overweight" rating and issued a $30.00 price target on shares of Enovix in a report on Thursday, February 20th. Finally, Benchmark restated a "buy" rating and set a $25.00 price objective on shares of Enovix in a report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $20.30.
Check Out Our Latest Stock Analysis on ENVX
Enovix Stock Down 6.1 %
ENVX stock traded down $0.59 during midday trading on Monday, reaching $9.04. The company had a trading volume of 5,244,824 shares, compared to its average volume of 7,053,040. The company has a 50 day moving average of $11.22 and a two-hundred day moving average of $10.26. Enovix has a 1 year low of $5.70 and a 1 year high of $18.68. The company has a market capitalization of $1.61 billion, a P/E ratio of -6.23 and a beta of 1.87. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99.
Insider Buying and Selling at Enovix
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the transaction, the director now owns 99,497 shares in the company, valued at approximately $968,105.81. The trade was a 42.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 15.70% of the company's stock.
Institutional Trading of Enovix
Several large investors have recently bought and sold shares of the company. B. Riley Wealth Advisors Inc. lifted its holdings in shares of Enovix by 104.6% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 23,575 shares of the company's stock worth $256,000 after buying an additional 12,050 shares in the last quarter. Integrated Advisors Network LLC acquired a new stake in Enovix in the 4th quarter valued at about $148,000. PharVision Advisers LLC acquired a new stake in shares of Enovix in the fourth quarter valued at $149,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Enovix by 23.2% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 302,347 shares of the company's stock valued at $3,287,000 after purchasing an additional 56,986 shares in the last quarter. Finally, Two Sigma Investments LP boosted its holdings in shares of Enovix by 910.3% in the fourth quarter. Two Sigma Investments LP now owns 151,770 shares of the company's stock valued at $1,650,000 after acquiring an additional 136,747 shares in the last quarter. 50.92% of the stock is owned by institutional investors.
Enovix Company Profile
(
Get Free Report)
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
